Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
263,509
-
Shares change
-
+76,709
-
Total reported value, excl. options
-
$3,934,189
-
Value change
-
+$1,016,833
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$14.93
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2023
4 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2023.
NovoCure Ltd - Common Stock (NVCR) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 263,509 shares
of 111,111,111 outstanding shares and own 0.24% of the company stock.
Largest 10 shareholders include FMR LLC (15,962,767 shares), VANGUARD GROUP INC (9,759,098 shares), Capital International Investors (8,861,871 shares), BlackRock Inc. (8,792,035 shares), BAILLIE GIFFORD & CO (4,840,141 shares), STATE STREET CORP (3,863,549 shares), Capital World Investors (3,276,996 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,253,225 shares), TWO SIGMA ADVISERS, LP (1,634,500 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,591,963 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.